Clinicopathological features, management and outcome of patients with poorly-differentiated oral and oropharyngeal squamous cell carcinoma
Introduction
Poorly differentiated disease is a rare pathological type that accounts for approximately 5% of all patients with oral and oropharyngeal squamous cell carcinoma (Feng et al., 2015, Feng et al., 2016b, Feng et al., 2017). Accumulating evidence has shown that poor differentiation of oral and oropharyngeal squamous cell carcinoma is significantly associated with more aggressive clinicopathological features, for example, lymph node metastasis and extracapsular spread (ECS) of the primary tumor, and a higher risk of developing local and/or regional recurrence and/or distant metastases after primary treatment (Liao et al., 2008, Liao et al., 2007). Therefore, poorly differentiated OOSCC patients were believed to have a worse prognosis than those with moderately and well-differentiated diseases (Brandwein-Gensler et al., 2005, Kang et al., 2011b).
Our recent study found that the degree of differentiation was the decisive factor in long-term survival for patients suffering from multiple synchronous primary cancers involving oral and oropharyngeal subsites (Feng et al., 2016b). However, we also made the interesting observation in our clinical practice that poor differentiation was not often an independent prognostic factor for selected oral and oropharyngeal squamous cell carcinoma (Feng et al., 2015, Niu et al., 2014). The above results have shown that the value of histological classifications is variable across different OOSCC populations. Because poorly differentiated OOSCC is relatively uncommon, its clinicopathological features, risk stratification, and principles of management still lack evidence from large-sample clinical studies, especially for the northern Chinese population. This low incidence rate made it very difficult to perform prospective, evidence-based studies for these particular tumors.
The purpose of this retrospective study was to explore the clinicopathological features of patients with poorly differentiated OOSCC in the Northern Chinese population (immunohistochemistry (IHC) of p16 protein and in situ hybridization (ISH) of HPV 16/18-specific DNA for oropharyngeal cancers were detected). In addition, we aimed to sort the risk classification of these OOSCC patients into high- and low-risk populations to aid surgeons in adopting a more strategic treatment policy in the future.
Section snippets
Patients
This study was conducted in full accordance with ethical principles, including the World Medical Association Declaration of Helsinki (2002 version), and with the approval of the Institutional Review Board of the Beijing Stomatological Hospital of Capital Medical University. The treatment, including surgery, radiotherapy, and chemoradiotherapy, was performed after obtaining written informed consent from all patients. The study population comprised all patients who were treated in the Department
Patients and baseline data
A total of 118 consecutive OOSCC patients with poorly differentiated diseases were enrolled in the study. There were 83 (70.3%) men and 35 (29.7%) women. The mean age was 58.6 ± 13.3 years. Most patients had a tumor on the tongue (35.6%), followed by the lower gingiva (14.4%), floor of the mouth (13.6%), cheek (11.0%), oropharynx (11.0%), upper gingiva (11.0%), and hard palate (3.4%). The T staging was as follows: T1 (n = 16, 13.6%), T2 (n = 43, 36.4%), T3 (n = 16, 13.6%), T4a (n = 39, 33.1%),
Discussion
Although it was well known that histological grade is one of the important prognostic factors in OOSCC, the precise risk stratification of traditional TNM stages for well- or poorly differentiated patients is inadequate (Kang et al., 2011a, Kang et al., 2011b). Our previous studies showed that the traditional TNM stage may not be the best prognostic factor in the presence of ECS, adjuvant treatments, and even some important biomarkers (Feng et al., 2014a, Feng et al., 2011). In this study, our
Conclusion
High LNR, oropharyngeal site, and advanced clinical stage constitute a model of risk stratification for poorly differentiated patients with OOSCC. If the score for risk ≥2, that is to say, if two or more risk factors are present, surgery and adjuvant chemoradiotherapy give the best prognosis. However, if the risk score is 0 or 1, that is to say, if only one or no risk factor is present, surgery alone can give a better quality of life, decrease the cost of treatment, and decrease the trauma
Disclosure
None declared.
Acknowledgments
This work was supported by the National Natural Science Foundation of China (81302350 and 81570957), the Beijing Science and Technology Committee (Z161100000516201), the Beijing Nova Programme (Z151100000315045), China, the Discipline Construction Fund of Beijing Stomatological Hospital (15-09-12), and undergraduate scientific research innovation projects of Capital medical university (XSKY2017180).
References (25)
- et al.
Oral squamous cell carcinoma: a clinicopathologic review of 233 cases in Lagos, Nigeria
J Oral Maxillofac Surg
(2008) - et al.
Selective versus comprehensive neck dissection in the treatment of patients with a pathologically node-positive neck with or without microscopic extracapsular spread in oral squamous cell carcinoma
Int J Oral Maxillofac Surg
(2014) - et al.
Risk factors and treatment of contralateral neck recurrence for unilateral oral squamous cell carcinoma: a retrospective study of 1482 cases
Oral Oncol
(2014) - et al.
Nodal yield: is it a prognostic factor for head and neck squamous cell carcinoma?
J Oral Maxillofac Surg
(2015) - et al.
Risk factors for patients with multiple synchronous primary cancers involving oral and oropharyngeal subsites
Oral Surg Oral Med Oral Pathol Oral Radiol
(2016) - et al.
Second primary cancer after index head and neck squamous cell carcinoma in northern China
Oral Surg Oral Med Oral Pathol Oral Radiol
(2017) - et al.
Risk factors for relapse of middle-stage squamous cell carcinoma of the submandibular region and floor of mouth: the importance of en bloc resection
Br J Oral Maxillofac Surg
(2016) - et al.
Outcome analysis of patients with well-differentiated oral cavity squamous cell carcinoma
Oral Oncol
(2011) - et al.
The number of pathologically positive lymph nodes and pathological tumor depth predicts prognosis in patients with poorly differentiated squamous cell carcinoma of the oral cavity
Int J Radiat Oncol Biol Phys
(2011) - et al.
Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy
Oral Oncol
(2012)